BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Experts in dermatology, medical aesthetics, tissue engineering - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.rbcconsultants.com
X-WR-CALDESC:Events for Experts in dermatology, medical aesthetics, tissue engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260618T190000
DTEND;TZID=America/New_York:20260618T200000
DTSTAMP:20260620T192118
CREATED:20260604T195842Z
LAST-MODIFIED:20260604T195842Z
UID:1675-1781809200-1781812800@www.rbcconsultants.com
SUMMARY:Choose Fast Relief From Hives and Itch With RHAPSIDO®
DESCRIPTION:Speakers: Brad Peter Glick\, DO\, MPH\, FAAD\, FAOCD\, FACOFP Dermatologist\, Dermatologic Surgeon and Principal Investigator Larkin Health System – GSI Clinical Research Miami\, Florida \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Choose Fast Relief From Hives and Itch With RHAPSIDO®: An Oral Targeted Treatment Approach for Uncontrolled Chronic Spontaneous Urticaria Despite Antihistamine Use This presentation will explore a different approach in patient care with RHAPSIDO by explaining the role of Bruton’s tyrosine kinase (BTK) in CSU pathophysiology and MOA of RHAPSIDO as the first-of-its-kind oral BTK inhibitor (BTKi) therapy\, exploring clinical data on RHAPSIDO\, including efficacy\, safety\, and onset of action\, to support informed treatment decisions after antihistamines fall short\, and providing real-world perspectives from expert peers on how RHAPSIDO may help your appropriate patients. \nREGISTER
URL:https://www.rbcconsultants.com/event/choose-fast-relief-from-hives-and-itch-with-rhapsido/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260609T190000
DTEND;TZID=America/New_York:20260609T200000
DTSTAMP:20260620T192118
CREATED:20260519T133211Z
LAST-MODIFIED:20260519T133211Z
UID:1667-1781031600-1781035200@www.rbcconsultants.com
SUMMARY:Discover the Science of VTAMA
DESCRIPTION:Speaker: Ben Ehst\, MD\, PhD Co-owner\, Chief Medical Officer (CMO) and Principal Investigator\, Oregon Medical Research Center Clinical Associate Professor\, Department of Dermatology\, Oregon Health & Science University Portland\, Oregon \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Discover the Science of VTAMA \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/discover-the-science-of-vtama-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260521T190000
DTEND;TZID=America/New_York:20260521T200000
DTSTAMP:20260620T192118
CREATED:20260410T173029Z
LAST-MODIFIED:20260410T173029Z
UID:1647-1779390000-1779393600@www.rbcconsultants.com
SUMMARY:Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
DESCRIPTION:Speaker: April W. Armstrong MD\, FAAD Professor and Chief of Dermatology UCLA Health Professor of Dermatology Associate Dean for Clinical Research Director of Clinical Research Support\, Southern California Clinical and Translational Science Institute \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema. Join April W. Armstrong\, MD\, MPH\, for a review of expert consensus on advanced topical nonsteroidal therapies for chronic hand eczema. This session highlights their role as effective\, steroid-sparing options\, particularly delgocitinib\, focusing on efficacy\, safety\, and quality-of-life improvements to support clinical decision-making. \nRegister
URL:https://www.rbcconsultants.com/event/expert-consensus-on-advanced-topical-nonsteroidal-therapies-for-chronic-hand-eczema/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260519T120000
DTEND;TZID=America/New_York:20260519T130000
DTSTAMP:20260620T192118
CREATED:20260410T155624Z
LAST-MODIFIED:20260506T014315Z
UID:1642-1779192000-1779195600@www.rbcconsultants.com
SUMMARY:Getting Started: The Lilly Support Experience
DESCRIPTION:Speaker: Amy Brennan Prior Authorization Coordinator Dermatology Associates Industry Relations Chair Biologic Coordinators of Dermatology Lynnfield\, Massachusetts \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n\n\n\n\n\n\n Heather Austin Sawrey is a nationally recognized dermatology biologics access expert and Certified Professional Coder with more than 15 years of experience supporting patients and providers in navigating the complex biologics reimbursement and access landscape. She currently serves as Lead Biologics Coordinator at George Washington University Department of Dermatology in Goldsboro\, North Carolina\, where she is solely responsible for managing access\, prior authorizations\, and ongoing therapy support for hundreds of patients on biologic treatments. Heather is widely respected for her deep expertise in managed care pharmacy approvals\, utilization management criteria\, PBM and specialty pharmacy pathways\, and manufacturer and foundation patient assistance programs. A passionate patient advocate\, she is known for achieving exceptional access outcomes while educating clinics and stakeholders on best practices for initiating and maintaining biologic therapies.\n\n\n\n\n\n\n\n\n\nRegister
URL:https://www.rbcconsultants.com/event/getting-started-the-lilly-support-experience-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260507T190000
DTEND;TZID=America/New_York:20260507T200000
DTSTAMP:20260620T192118
CREATED:20260410T173135Z
LAST-MODIFIED:20260410T173135Z
UID:1649-1778180400-1778184000@www.rbcconsultants.com
SUMMARY:Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from Expert Panel
DESCRIPTION:Speaker: April W. Armstrong\, MD\, FAAD Professor and Chief of Dermatology UCLA Health Professor of Dermatology Associate Dean for Clinical Research Director of Clinical Research Support\, Southern California Clinical and Translational Science Institute \n Moderator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from Expert Panel. Join April W. Armstrong\, MD\, FAAD\, for an expert-led overview of advanced topical nonsteroidal therapies for atopic dermatitis. This webinar highlights key consensus recommendations on emerging steroid-sparing treatments and their role as first-line options. Learn how to optimize long-term disease control\, improve patient outcomes\, and reduce corticosteroid exposure in clinical practice. \nRegister
URL:https://www.rbcconsultants.com/event/advanced-topical-nonsteroidal-therapies-for-atopic-dermatitis-consensus-statements-from-expert-panel/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260505T190000
DTEND;TZID=America/New_York:20260505T200000
DTSTAMP:20260620T192118
CREATED:20260410T155814Z
LAST-MODIFIED:20260410T155814Z
UID:1645-1778007600-1778011200@www.rbcconsultants.com
SUMMARY:Molluscum! Emerging Therapies and Management Strategies
DESCRIPTION:Speaker: Elizabeth (Lisa) Swanson\, MD Pediatric Dermatologist Ada West Dermatology \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n– This activity is jointly provided by Medical Education Resources and IDF. – This activity is supported by an educational grant from Pelthos Therapeutics. This activity has been designed to meet the educational needs of health care professionals involved in the care of patients with molluscum contagiosum. Accreditation Statement In support of improving patient care\, this activity has been planned and implemented by Medical Education Resources (MER) and IDF. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, to provide continuing education for the healthcare team. \nPlease join us for our next IDF Educational Series Webinar: Molluscum! Emerging Therapies and Management Strategies. ACCREDITED PROGRAM 1 AMA PRA Category 1 Credits™ & 1 ANCC Nursing Contact Hours In this webinar\, Elizabeth (Lisa) Swanson\, MD will provide a concise overview of molluscum contagiosum\, including its natural course\, evidence-based management\, and emerging treatment options. Participants will gain practical\, evidence-based insights applicable to dermatology and pediatric clinical practice\, optimizing treatment selection and improving patient and caregiver outcomes. \nRegister
URL:https://www.rbcconsultants.com/event/molluscum-emerging-therapies-and-management-strategies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260428T190000
DTEND;TZID=America/New_York:20260428T200000
DTSTAMP:20260620T192118
CREATED:20260420T164332Z
LAST-MODIFIED:20260420T164332Z
UID:1661-1777402800-1777406400@www.rbcconsultants.com
SUMMARY:Discover the Science of VTAMA
DESCRIPTION:Speaker: Adelaide Hebert\, MD\, FAAD Chief of Pediatric Dermatology McGovern Medical School UTHealth Houston Children’s Memorial Hermann Hospital Houston\, Texas \n Moderator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Discover the Science of VTAMA \n  \nRegister
URL:https://www.rbcconsultants.com/event/discover-the-science-of-vtama/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260423T190000
DTEND;TZID=America/New_York:20260423T200000
DTSTAMP:20260620T192118
CREATED:20260413T150836Z
LAST-MODIFIED:20260413T150855Z
UID:1652-1776970800-1776974400@www.rbcconsultants.com
SUMMARY:The Innovation of a Targeted Oral Peptide in Moderate to Severe Plaque Psoriasis
DESCRIPTION:Speaker: Eingun James Song\, MD\, FAAD Board-certified Dermatologist Co-Chief Medical Officer Director of Clinical Research Frontier Dermatology Pacific Northwest Dr Song is a board-certified dermatologist\, Co-Chief Medical Officer\, and Director of Clinical Research for Frontier Dermatology in the Pacific Northwest. He is clinical instructor at the University of Washington and is a nationally recognized key opinion leader in psoriasis\, atopic dermatitis\, and hidradenitis suppurativa. \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: The Innovation of a Targeted Oral Peptide in Moderate to Severe Plaque Psoriasis PROGRAM OBJECTIVES 1. Review unmet need in psoriasis 2. Introduce ICOTYDE mechanism of action 3. Discuss key safety and efficacy results from the ICONIC clinical trial program ICOTYDE is the first and only IL-23 receptor-targeted oral peptide in a once-daily pill for moderate to severe plaque psoriasis in adults and pediatric patients 12 years of age and older weighing at least 40 kg. \n  \nRegister
URL:https://www.rbcconsultants.com/event/the-innovation-of-a-targeted-oral-peptide-in-moderate-to-severe-plaque-psoriasis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260421T190000
DTEND;TZID=America/New_York:20260421T200000
DTSTAMP:20260620T192118
CREATED:20260414T155223Z
LAST-MODIFIED:20260420T173334Z
UID:1654-1776798000-1776801600@www.rbcconsultants.com
SUMMARY:Demand More With BIMZELX:  Transformative Results for Managing  Hidradenitis Suppurativa
DESCRIPTION:Speakers: Michelle Tarbox\, MD Associate Professor\, Chair and Program Director School of Medicine | Dermatology Texas Tech University Health Sciences Center School of Medicine \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Bimzelx: A Single Treatment Option for Patients with HS or Psoriatic Disease with the First and Only Approved IL-17A and IL-17F Inhibitors \n  \nRegister
URL:https://www.rbcconsultants.com/event/a-single-treatment-option-for-patients-with-hs-or-psoriatic-disease/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260407T190000
DTEND;TZID=America/New_York:20260407T200000
DTSTAMP:20260620T192118
CREATED:20260401T212719Z
LAST-MODIFIED:20260401T212719Z
UID:1639-1775588400-1775592000@www.rbcconsultants.com
SUMMARY:Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies
DESCRIPTION:Speakers: Naiem T. Issa\, MD\, PhD\, FAAD Dermatologist and Drug Discovery Researcher Assistant Professor of Dermatology\, University of Miami School of Medicine George Washington University School of Medicine and Health Sciences Vienna\, Virginia and Mona Shahriari\, MD\, FAAD Associate Clinical Professor of Dermatology\, Yale University School of Medicine Co-Founder/Partner\, Central Connecticut Dermatology Associate Director of Clinical Trials\, CCD Research\, Central Connecticut Dermatology \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director\, Physicians Skin Care\, PLLC\, Louisville\, KY\, DermResearch\, PLLC\, Louisville\, KY\, Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies Part 1: Deeper Understanding of Atopic Dermatitis This educational webinar will provide an overview of moderate-to-severe atopic dermatitis as a chronic\, relapsing inflammatory disease driven by type 2 immune dysregulation and skin barrier dysfunction. Naiem T. Issa\, MD\, PhD\, FAAD will review its clinical presentation\, disease burden\, impact on quality of life\, and current management challenges to support informed clinical decision-making. Part 2: Explore EBGLYSS®(lebrikizumab-lbkz) Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”\, an event where Mona Shahriari\, MD\, FAAD will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data\, safety\, dosing information\, and how to get patients started on EBGLYSS. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/advancing-care-in-moderate-to-severe-atopic-dermatitis-disease-insights-and-emerging-targeted-therapies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260406T190000
DTEND;TZID=America/New_York:20260406T200000
DTSTAMP:20260620T192118
CREATED:20260320T194800Z
LAST-MODIFIED:20260320T194800Z
UID:1637-1775502000-1775505600@www.rbcconsultants.com
SUMMARY:Redefining Retinoid Therapy with Breakthrough Technology and Clinical Performance
DESCRIPTION:Speaker: Vivian Bucay\, MD\, FAAD Board-Certified Dermatologist Founder & President\, Bucay Center for Dermatology and Aesthetics Clinical Assistant Professor\, UT Health Science Center at San Antonio\, Department of Physician Assistant Studies San Antonio\, Texas \nModerator: Roxane Chabot President RBC Consultants \nPlease join us for our next RBC Consultants Educational Series Webinar: AlphaRet®: Redefining Retinoid Therapy with Breakthrough Technology and Clinical Performance. This webinar reviews the science and clinical role of retinoids\, including their benefits and common limitations such as irritation and instability. Attendees will be introduced to AlphaRet®\, a novel “pro-retinoic acid” technology designed to enhance efficacy while improving tolerability. Clinical data comparing AlphaRet to traditional retinoids\, including tretinoin and retinol\, will be highlighted\, along with practical guidance on incorporating AlphaRet products into treatment regimens for aging and acne-prone skin. \n*The first 50 US dermatology healthcare providers who attend the entire webinar will receive a trade size AlphaRet® (one per address) from Skinbetter. Products will be distributed by RBC Consultants from Skinbetter based on current inventory. Requests for specific products will not be taken. Shipments will be fulfilled within approximately 12 weeks following the webinar. This program is only open to US dermatology healthcare providers. PLEASE BE SURE TO REGISTER WITH THE ADDRESS YOU WOULD LIKE THE PRODUCT SHIPPED TO. ADDRESS CHANGES WILL NOT BE ACCEPTED. For questions about the product giveaway\, please contact info@rbcconsultants.com. In order to join the webinar successfully and qualify for the product giveaway\, you must provide us your full continental US mailing address\, NPI number\, and tune in from a computer not blocked by a corporate or institutional firewall\, VPN\, anti-tracking\, or anti-cookie software. You must also have JavaScript and Cookies enabled to access this webinar. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/redefining-retinoid-therapy-with-breakthrough-technology-and-clinical-performance/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260324T120000
DTEND;TZID=America/New_York:20260324T130000
DTSTAMP:20260620T192118
CREATED:20260313T155139Z
LAST-MODIFIED:20260313T155139Z
UID:1634-1774353600-1774357200@www.rbcconsultants.com
SUMMARY:Getting Started: The Lilly Support Experience
DESCRIPTION:Speakers: Brandis Boyd-Cooper Clinical Manager Lead Biologic Coordinator Brandis Boyd‑Cooper is a Clinical Manager and Lead Biologic Coordinator with over two decades of experience in dermatology and immunology. She specializes in biologics management\, hub services\, and patient‑provider coordination\, supporting both individual practices and large physician networks. Brandis is also a sought‑after speaker and advisory board contributor for major pharmaceutical companies\, offering expertise on enrollment processes\, bridge programs\, and hub service improvements. Her clinical background includes scribing\, phlebotomy\, surgical support\, and staff training. \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Getting Started: The Lilly Support Experience This program will provide a tailored overview of Lilly Support Services and how to get patients started\, with a focus on access\, enrollment\, and quick start treatment processes. This program is sponsored by\, and the speaker is presenting on behalf of\, Lilly USA\, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/getting-started-the-lilly-support-experience/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251209T190000
DTEND;TZID=America/New_York:20251209T200000
DTSTAMP:20260620T192118
CREATED:20251205T133959Z
LAST-MODIFIED:20251205T133959Z
UID:1543-1765306800-1765310400@www.rbcconsultants.com
SUMMARY:Now Approved: A new path forward with RHAPSIDO® (remibrutinib)
DESCRIPTION:Speaker: Neal Bhatia\, MD\, FAAD Director of Clinical Dermatology Therapeutics Clinical Research \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Now Approved: A new path forward with RHAPSIDO® (remibrutinib) In this program\, you’ll gain the tools to: – Recognize when to consider escalation of therapy – Understand the unique mechanism of action of RHAPSIDO® – Identify patients in your practice who may be ready for RHAPSIDO® \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/now-approved-a-new-path-forward-with-rhapsido-remibrutinib-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251208T190000
DTEND;TZID=America/New_York:20251208T200000
DTSTAMP:20260620T192118
CREATED:20251123T170112Z
LAST-MODIFIED:20251123T170112Z
UID:1536-1765220400-1765224000@www.rbcconsultants.com
SUMMARY:The Puzzle of Itch in Elderly Adults: Putting the Pieces Together
DESCRIPTION:Speaker: Daniel Butler\, MD Associate Professor\, Division of Dermatology Assistant Dean of Student Affairs Director\, Inflammatory and Aging Skin Research Program University of Arizona College of Medicine Tucson\, AZ \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: The Puzzle of Itch in Elderly Adults: Putting the Pieces Together During this ADVENT webinar Dr. Butler will address the complex and often underrecognized issue of pruritus in elderly patients. His presentation will focus specifically on the distinct clinical features of common pruritic skin conditions\, the role of type 2 inflammation in the pathophysiology of these conditions\, and the multifactorial burden complicating clinical management​. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/the-puzzle-of-itch-in-elderly-adults-putting-the-pieces-together/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251204T190000
DTEND;TZID=America/New_York:20251204T200000
DTSTAMP:20260620T192118
CREATED:20251119T163503Z
LAST-MODIFIED:20251119T163503Z
UID:1531-1764874800-1764878400@www.rbcconsultants.com
SUMMARY:Transformative Treatments Results in Plaque Psoriasis and Psoriatic Arthritis
DESCRIPTION:Speaker: April W. Armstrong\, MD\, FAAD Professor and Chief of Dermatology UCLA Health Professor of Dermatology Associate Dean for Clinical Research Director of Clinical Research Support\, Southern California Clinical and Translational Science Institute (SC CTSI) \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Transformative Treatments Results in Plaque Psoriasis and Psoriatic Arthritis with the First and Only Approved IL – 17A and IL17F Inhibitor. BIMZELX is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy\, ​active psoriatic arthritis\, active non-radiographic axial spondyloarthritis with objective signs of inflammation\, active ankylosing spondylitis\, ​and moderate-to-severe hidradenitis suppurativa. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/transformative-treatments-results-in-plaque-psoriasis-and-psoriatic-arthritis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251202T190000
DTEND;TZID=America/New_York:20251202T200000
DTSTAMP:20260620T192118
CREATED:20251124T145227Z
LAST-MODIFIED:20251124T145227Z
UID:1538-1764702000-1764705600@www.rbcconsultants.com
SUMMARY:Discover the Latest Chapter in the COSENTYX® (secukinumab) Story
DESCRIPTION:Speaker: Chesahna Kindred\, MD\, MBA\, FAAD President Kindred Hair & Skin Center Associate Clinical Professor Howard University \n Moderator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Discover the Latest Chapter in the COSENTYX® (secukinumab) Story Join Chesahna Kindred\, MD\, MBA\, FAAD as she shares exciting new insights from the SUNRISE and SUNSHINE trials. Discover how COSENTYX delivers sustained efficacy and quality-of-life improvements for HS patients. Webinar Objectives: – Learn about new 4-year long-term HS data for COSENTYX – Understand the “Window of Opportunity” for using COSENTYX in appropriate moderate HS patients – Identify practical strategies for integrating these insights into your HS patient care \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/discover-the-latest-chapter-in-the-cosentyx-secukinumab-story/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251202T190000
DTEND;TZID=America/New_York:20251202T200000
DTSTAMP:20260620T192118
CREATED:20251119T164245Z
LAST-MODIFIED:20251119T164245Z
UID:1533-1764702000-1764705600@www.rbcconsultants.com
SUMMARY:The Science of Renewal: Understanding Menopausal Skin Changes and Innovative Care Approaches
DESCRIPTION:Speaker: Doris Day\, MD\, FAAD\, FA Clinical Professor NYU Grossman School of Medicine\, Ronald O. Perelman Department of Dermatology Founder & Board-Certified Dermatologist Day Dermatology and Aesthetics New York City \nModerator: Roxane Chabot President RBC Consultants \nPlease join us for our next RBC Consultants Educational Series Webinar: The Science of Renewal: Understanding Menopausal Skin Changes and Innovative Care Approaches. Join us for an educational deep dive into the biological and dermatological impacts of hormonal changes during perimenopause and menopause. This session will explore the science behind estrogen decline\, its systemic and skin-specific effects\, and emerging approaches to supporting skin health through biotechnology and topical innovation. Attendees will gain a clearer understanding of the stages of reproductive aging\, key hormonal shifts\, and evidence-based strategies for restoring hydration\, firmness\, and radiance in estrogen-deficient skin. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/the-science-of-renewal-understanding-menopausal-skin-changes-and-innovative-care-approaches/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251201T190000
DTEND;TZID=America/New_York:20251201T203000
DTSTAMP:20260620T192118
CREATED:20251119T163327Z
LAST-MODIFIED:20251119T163327Z
UID:1529-1764615600-1764621000@www.rbcconsultants.com
SUMMARY:Atopic Dermatitis and Prurigo Nodularis: Clarifying Perspectives and Common Misconceptions
DESCRIPTION:Speakers: Sarina Elmariah MD\, PhD Associate Professor Dermatology Director UCSF Centre for Itch and Neurosensory Disorders University of California San Francisco\, California\, US Jason Hawkes MD\, MS Board-certified Dermatologist Investigator\, Oregon Medical Research Center Portland\, OR Councilor\, International Psoriasis Council NPF Medical Board and Scientific Advisory Committee \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Atopic Dermatitis and Prurigo Nodularis: Clarifying Perspectives and Common Misconceptions This ADVENT program will feature a comprehensive presentation led by Dr. Sarina Elmariah and Dr. Jason Hawkes\, focusing on the clinical presentation and underlying type 2 inflammation in atopic dermatitis (AD) and prurigo nodularis (PN). The session will explore the pathomechanisms of AD\, providing a deeper understanding of its immune and inflammatory drivers\, while also addressing common myths and misconceptions about PN. Through expert insights and evidence-based discussion\, the program aims to clarify the connections and distinctions between AD and PN\, ultimately enhancing clinical understanding and improving patient care for these type 2 inflammation–driven skin conditions. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/atopic-dermatitis-and-prurigo-nodularis-clarifying-perspectives-and-common-misconceptions/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251125T190000
DTEND;TZID=America/New_York:20251125T203000
DTSTAMP:20260620T192118
CREATED:20251119T162823Z
LAST-MODIFIED:20251119T162823Z
UID:1527-1764097200-1764102600@www.rbcconsultants.com
SUMMARY:Beyond Plaques & Nodules: Understanding IL-17 Biology Across Disease States
DESCRIPTION:Speaker: Naiem T. Issa\, MD\, PhD\, FAAD Dermatologist & Dermatologic Surgeon Forefront Dermatology Vienna\, Virginia \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Beyond Plaques & Nodules: Understanding IL-17 Biology Across Disease States This webinar explores the IL-17 family of cytokines\, key mediators of immune regulation that play crucial roles in maintaining tissue homeostasis and driving inflammation. We will discuss how dysregulation of IL-17 signaling contributes to the pathogenesis of chronic inflammatory diseases\, including psoriasis\, psoriatic arthritis\, and hidradenitis suppurativa. The session will highlight recent advances in understanding the molecular pathways linking IL-17 activity to skin and joint inflammation as well as the different sources of IL-17 cytokine production (IL-23-dependent and IL-23-independent pathways). Attendees will gain in-depth insights into the biology and clinical relevance of IL-17 cytokines contextualized for chronic inflammatory dermatoses. Learning objectives: – Describe the biological functions of the IL-17 family of cytokines in maintaining immune homeostasis and promoting inflammation. – Explain the role of IL-17 dysregulation in the pathogenesis of psoriasis\, psoriatic arthritis\, and hidradenitis suppurativa. – Evaluate gene expression signatures reflecting pro-inflammatory pathways in psoriasis and hidradenitis and appreciate how dual blockade of IL-17A & IL-17F contributes to normalization of these gene signatures and ultimately reduction of key immune cell activity such as tissue-resident memory T cells and neutrophils. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/beyond-plaques-nodules-understanding-il-17-biology-across-disease-states/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251117T190000
DTEND;TZID=America/New_York:20251117T200000
DTSTAMP:20260620T192118
CREATED:20251028T183429Z
LAST-MODIFIED:20251028T183509Z
UID:1442-1763406000-1763409600@www.rbcconsultants.com
SUMMARY:A Breakthrough for Hands That Need to Get UP and GO Introducing ANZUPGO®
DESCRIPTION:Speaker: David Cotter\, MD\, PhD Medical Director\, Lakes Dermatology Fellow\, American Academy of Dermatology Vice President and Director of Clinical Research Assistant Clinical Professor of Medicine and Dermatology University of Nevada Las Vegas Las Vegas\, Nevada \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: A Breakthrough for Hands That Need to Get UP and GO Introducing ANZUPGO®: The FIRST and ONLY FDA-Approved Treatment for Moderate to Severe CHE \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/a-breakthrough-for-hands-that-need-to-get-up-and-go-introducing-anzupgo-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251106T190000
DTEND;TZID=America/New_York:20251106T200000
DTSTAMP:20260620T192118
CREATED:20251028T183114Z
LAST-MODIFIED:20251102T162625Z
UID:1440-1762455600-1762459200@www.rbcconsultants.com
SUMMARY:Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway
DESCRIPTION:Speaker: Ben Lockshin\, MD\, FAAD Board‑Certified Dermatologist U.S. Dermatology Partners Director\, Clinical Trials Center U.S. Dermatology Partners \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review the evolving understanding of atopic dermatitis (AD)\, diagnosis\, management\, and the patient journey – Evaluate a treatment option for mild to moderate AD – Understand the indicated patient population for treatment \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/mild-to-moderate-atopic-dermatitis-burden-of-disease-and-a-topical-pathway-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251030T190000
DTEND;TZID=America/New_York:20251030T200000
DTSTAMP:20260620T192118
CREATED:20251025T123218Z
LAST-MODIFIED:20251025T123218Z
UID:1434-1761850800-1761854400@www.rbcconsultants.com
SUMMARY:Now Approved: A new path forward with RHAPSIDO® (remibrutinib)
DESCRIPTION:Speaker: David Cotter\, MD\, PhD Medical Director\, Lakes Dermatology Fellow\, American Academy of Dermatology  Vice President and Director of Clinical Research Assistant Clinical Professor of Medicine and Dermatology University of Nevada Las Vegas Las Vegas\, Nevada \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Now Approved: A new path forward with RHAPSIDO® (remibrutinib) In this program\, you’ll gain the tools to: – Recognize when to consider escalation of therapy – Understand the unique mechanism of action of RHAPSIDO® – Identify patients in your practice who may be ready for RHAPSIDO® \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/now-approved-a-new-path-forward-with-rhapsido-remibrutinib/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251022T190000
DTEND;TZID=America/New_York:20251022T200000
DTSTAMP:20260620T192118
CREATED:20251016T121410Z
LAST-MODIFIED:20251016T121410Z
UID:1431-1761159600-1761163200@www.rbcconsultants.com
SUMMARY:Clinical Insights Across the Skin and Joints
DESCRIPTION:Speaker: Joe K. Tung\, MD\, MBA\, FAAD Director\, Clinical Trials Unit Medical Director\, Falk Dermatology Associate Director\, Dermatology Residency Program Department of Dermatology University of Pittsburgh Medical Center \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: Shared Pathways: Clinical Insights Across the Skin and Joints \nPLEASE CLICK HERE TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/clinical-insights-across-the-skin-and-joints/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251016T200000
DTEND;TZID=America/New_York:20251016T210000
DTSTAMP:20260620T192118
CREATED:20250925T233648Z
LAST-MODIFIED:20250925T233648Z
UID:1417-1760644800-1760648400@www.rbcconsultants.com
SUMMARY:Vitiligo Real-World Case Studies
DESCRIPTION:Speaker: Karan Lal\, DO Director of Pediatric Dermatology and Cosmetic Surgery Affiliated Dermatology \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Vitiligo Real-World Case Studies. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review cases of real-world nonsegmental vitiligo patients treated with a topical treatment option – Review clinical trial data supporting the use of a topical treatment option in nonsegmental vitiligo patients – Discuss clinical pearls to help effectively manage your nonsegmental vitiligo patients \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/vitiligo-real-world-case-studies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T190000
DTEND;TZID=America/New_York:20251014T200000
DTSTAMP:20260620T192118
CREATED:20251009T152913Z
LAST-MODIFIED:20251009T152913Z
UID:1429-1760468400-1760472000@www.rbcconsultants.com
SUMMARY:RYBREVANT® (amivantamab-vmjw) + LAZCLUZE® (lazertinib) Proactive Strategies to Help Patients
DESCRIPTION:Please join us for our next ODS Educational Series Webinar: RYBREVANT® (amivantamab-vmjw) + LAZCLUZE® (lazertinib) Proactive Strategies to Help Patients on Therapy. Take part in a deep dive into prophylactic approaches associated with RYBREVANT® + LAZCLUZE® treatment and gain insights about efficacy and safety. Please read full Prescribing Information for RYBREVANT® (https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RYBREVANT-pi.pdf) and full Prescribing Information for LAZCLUZE® (https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/LAZCLUZE-pi.pdf). \nModerator: Mario E. Lacouture\, MD\, FAAD Founding President\, Oncodermatology Society Chief\, Dermatology Division\, Department of Medicine NYU Grossman Long Island School of Medicine Medical Director\, Symptom Management Program Perlmutter Cancer Center NYU Langone Hospital – Long Island \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/rybrevant-amivantamab-vmjw-lazcluze-lazertinib-proactive-strategies-to-help-patients/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T190000
DTEND;TZID=America/New_York:20251014T200000
DTSTAMP:20260620T192118
CREATED:20251007T162520Z
LAST-MODIFIED:20251007T162520Z
UID:1425-1760468400-1760472000@www.rbcconsultants.com
SUMMARY:Demand More with Bimzelx
DESCRIPTION:Speaker: Christopher Sayed\, MD Professor\, Department of Dermatology University of North Carolina Chapel Hill\, North Carolina \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/demand-more-with-bimzelx/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251013T190000
DTEND;TZID=America/New_York:20251013T200000
DTSTAMP:20260620T192118
CREATED:20250925T233510Z
LAST-MODIFIED:20250925T233527Z
UID:1415-1760382000-1760385600@www.rbcconsultants.com
SUMMARY:Transform Your Patient’s Journey. Adbry®: Early Itch Relief and Long-Term Disease Control
DESCRIPTION:Speaker: Angela Lamb\, MD Dermatology System Vice Chair Clinical Operations and Strategy Icahn School of Medicine Mount Sinai Hospital New York\, NY \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nCLICK HERE TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/transform-your-patients-journey-adbry-early-itch-relief-and-long-term-disease-control/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251009T213000
DTEND;TZID=America/New_York:20251009T223000
DTSTAMP:20260620T192118
CREATED:20250930T223337Z
LAST-MODIFIED:20250930T223337Z
UID:1421-1760045400-1760049000@www.rbcconsultants.com
SUMMARY:Advancing Patient Care in Vitiligo:  Insights and Practical Management Strategies
DESCRIPTION:Speakers: Erik Domingues\, MD\, FAAD Modern Dermatology of Massachusetts Erika Page Founder/CEO\, Living Dappled \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Advancing Patient Care in Vitiligo: Insights and Practical Management Strategies. This is an educational program brought to you by Incyte Dermatology. Please join us for an expert-led discussion on the pathophysiology of vitiligo\, challenges in disease management\, goals of therapy\, and best practices for patient communication and shared decision-making. We will also gain perspectives from a patient living with vitiligo\, to better understand the impact of disease and how to support shared decision-making. \nPlease note this program is intended for US healthcare professionals (HCPs) only. This program is sponsored by Incyte Corporation and is not eligible for CME credits. This is an educational event intended only for appropriate healthcare professionals. Spouses\, guests\, and other individuals who are not the intended audience of this educational program are not permitted to attend. Healthcare professionals who are subject to federal\, state or local laws or government ethics restrictions may not attend. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/advancing-patient-care-in-vitiligo-insights-and-practical-management-strategies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251006T190000
DTEND;TZID=America/New_York:20251006T200000
DTSTAMP:20260620T192118
CREATED:20250916T010631Z
LAST-MODIFIED:20250916T010631Z
UID:1412-1759777200-1759780800@www.rbcconsultants.com
SUMMARY:A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg
DESCRIPTION:Speaker: Naiem Issa\, MD\, PHD Medical Director of Clinical Trials and Research\, Forefront Dermatology Adjunct Professor\, George Washington University School of Medicine and Health Sciences Voluntary Assistant Professor\, University of Miami Leonard M. Miller School of Medicine Clinical Instructor\, West Virginia School of Osteopathic Medicine \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDEF Educational Series Webinar: A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg — Full Speed A Head. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/a-new-treatment-for-adults-with-severe-alopecia-areata-leqselvi-deuruxolitinib-8mg-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250930T190000
DTEND;TZID=America/New_York:20250930T200000
DTSTAMP:20260620T192118
CREATED:20250916T010411Z
LAST-MODIFIED:20250916T010411Z
UID:1410-1759258800-1759262400@www.rbcconsultants.com
SUMMARY:Taltz for Today and Tomorrow
DESCRIPTION:Speaker: Pranav B. Sheth\, MD\, FAAD Board-Certified Dermatologist Dermatology & Skin Care Associates Volunteer Associate Professor of Dermatology University of Cincinnati College of Medicine \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nDr. Sheth has a background in both academic medicine and clinical dermatology. He has been an investigator in over 120 clinical trials\, teaches at the University of Cincinnati Department of Dermatology\, and is currently in a private practice in West Chester Ohio. He has publications in peer reviewed journals and has chapters in various books on psoriasis\, therapeutics\, and vitiligo. He is past president of the Cincinnati Dermatological Society\, and current Chair of the Scientific Poster Judging committee for the Ohio Dermatological Association. He has been voted in the list of Best Doctors by Cincinnati Magazine for the last 15+ years. His wife is a pediatric dermatologist in Cincinnati\, and his daughter is a Chief Resident in dermatology at Northwestern. Dr. Sheth loves teaching. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/taltz-for-today-and-tomorrow/
END:VEVENT
END:VCALENDAR